HSTM Stock Overview
Provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for HSTM from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
HealthStream, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$31.16 |
| 52 Week High | US$33.52 |
| 52 Week Low | US$23.92 |
| Beta | 0.39 |
| 1 Month Change | -0.48% |
| 3 Month Change | 7.04% |
| 1 Year Change | 18.39% |
| 3 Year Change | 19.85% |
| 5 Year Change | 11.41% |
| Change since IPO | 266.59% |
Recent News & Updates
Should You Be Adding HealthStream (NASDAQ:HSTM) To Your Watchlist Today?
Nov 28
Returns At HealthStream (NASDAQ:HSTM) Are On The Way Up
Nov 07Recent updates
Should You Be Adding HealthStream (NASDAQ:HSTM) To Your Watchlist Today?
Nov 28Returns At HealthStream (NASDAQ:HSTM) Are On The Way Up
Nov 07HealthStream, Inc.'s (NASDAQ:HSTM) Shareholders Might Be Looking For Exit
Aug 08We Ran A Stock Scan For Earnings Growth And HealthStream (NASDAQ:HSTM) Passed With Ease
Jul 17HealthStream, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Apr 24HealthStream GAAP EPS of $0.10 beats by $0.05, revenue of $65.64M misses by $0.63M
Jul 25HealthStream's (NASDAQ:HSTM) Returns Have Hit A Wall
Jun 24A Look At The Fair Value Of HealthStream, Inc. (NASDAQ:HSTM)
Jun 04We Discuss Why HealthStream, Inc.'s (NASDAQ:HSTM) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
May 14HealthStream up after-hours after earnings beat; raises FY 2021 guidance
Apr 26Returns At HealthStream (NASDAQ:HSTM) Appear To Be Weighed Down
Apr 08Has HealthStream, Inc. (NASDAQ:HSTM) Stock's Recent Performance Got Anything to Do With Its Financial Health?
Mar 21Have HealthStream, Inc. (NASDAQ:HSTM) Insiders Been Selling Their Stock?
Mar 03Shareholder Returns
| HSTM | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -4.9% | -4.6% | -4.0% |
| 1Y | 18.4% | 3.5% | 24.0% |
Return vs Industry: HSTM exceeded the US Healthcare Services industry which returned 4.3% over the past year.
Return vs Market: HSTM underperformed the US Market which returned 26.1% over the past year.
Price Volatility
| HSTM volatility | |
|---|---|
| HSTM Average Weekly Movement | 3.8% |
| Healthcare Services Industry Average Movement | 9.3% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: HSTM has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: HSTM's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 1,086 | Bobby Frist | www.healthstream.com |
HealthStream, Inc. provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs. It offers hStream, a technology platform that powers a range of healthcare workforce solutions.
HealthStream, Inc. Fundamentals Summary
| HSTM fundamental statistics | |
|---|---|
| Market cap | US$972.36m |
| Earnings (TTM) | US$19.71m |
| Revenue (TTM) | US$287.99m |
48.1x
P/E Ratio3.3x
P/S RatioIs HSTM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HSTM income statement (TTM) | |
|---|---|
| Revenue | US$287.99m |
| Cost of Revenue | US$96.84m |
| Gross Profit | US$191.16m |
| Other Expenses | US$171.45m |
| Earnings | US$19.71m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.65 |
| Gross Margin | 66.38% |
| Net Profit Margin | 6.84% |
| Debt/Equity Ratio | 0% |
How did HSTM perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield17%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 06:40 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HealthStream, Inc. is covered by 14 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Gillmor | Baird |
| Vincent Colicchio | Barrington Research Associates, Inc. |
| Richard Close | Canaccord Genuity |